Fresenius SE & Co. KGaA



 


In Pictures

Photo: Hirsch Pharmacy document 1462

The Hirsch Pharmacy opens in Frankfurt am Main. The Fresenius family assumes ownership in the 18th century.


Photo: The Hirsch Pharmacy in Frankfurt am Main. In 1912, 300dpi 1912

The pharmacist and proprietor of the Hirsch Pharmacy, Dr. Eduard Fresenius, founds the pharmaceutical company Dr. E. Fresenius. 

 
He expands the pharmacy laboratory into a small manufacturing operation. Its main products are pharmaceutical specialties such as injection solutions, serologic reagents and Bormelin nasal ointment.


Photo: Gluckensteinweg Innenansicht 1933/34

The manufacturing company is separated from the Hirsch Pharmacy and moves to Bad Homburg. Dr. Fresenius devotes more and more time to the company, which grows to around 400 employees.


Photo: Dr. Fresenius 1946

The unexpected death of Eduard Fresenius endangers the further existence of the pharmacy and manufacturing company, which now has only 30 employees.


Photo: Else_Fernau_Apotheke 1951

Else Fernau, the later Else Kröner, takes over responsibility for the pharmacy and company after she has obtained her degree in pharmacy studies.


Photo: Infusion_50er_Flaschen 1955

The infusion solutions product range is expanded.


Photo: Dialyse_1960er_Vertrieb 1966

Fresenius starts to sell dialysis machines and dialyzers manufactured by various foreign companies and gains substantial market shares.


Photo: Manufacturing dialyzers 1974

Fresenius starts to manufacture infusion solutions and medical disposables in St. Wendel, Saarland. Today, Fresenius produces highly innovative Polysulfone dialyzers in St. Wendel.


Photo: A2008 1979

In a newly-acquired factory in Schweinfurt, production of the A2008 dialysis machine begins and the machine is awarded a gold medal at the Leipzig Trade Fair.


Photo: Aktie 1982

The company is converted into a joint stock company.


Photo: Image: polysulfone fiber 1983

Fresenius takes up production of synthetic polysulfone fiber membranes for blood purification. These membranes today set the quality standards for dialyzers.


Photo: History 1986 1986

Fresenius launches preference shares on the stock exchange.


Photo: 1990Pharamaproduktion 1990

Fresenius employs 5,200 people; total sales exceed 1 billion deutsche marks.


Photo: 1996

Fresenius Medical Care is founded. Fresenius Medical Care today is the world's largest provider of dialysis products and dialysis services for individuals with chronic kidney failure.


Photo: Friedberg_Luft 1997

Fresenius' new infusion solution factory in Friedberg/Hesse, the most modern in Europe, goes into operation. Consolidated sales amount to approximately 7.5 billion deutsche marks.


Photo: Image Headoffice Bad Homburg 1998
Fresenius acquires the international nutrition business of Pharmacia & Upjohn. In 1999, a new company, Fresenius Kabi AG, is created through the merger with the Fresenius Pharma Division. Fresenius Kabi is the European leader in the field of nutrition and infusion therapy with subsidiaries and distributors worldwide.


Fresenius moves into the new head office in Bad Homburg. Fresenius has nearly 39,000 employees worldwide.

Photo: 1999

Fresenius Kabi (formerly: Fresenius Pharma) and Fresenius ProServe (formerly: Projects & Services) become legally independent business segments.

At Fresenius Medical Care, the 100,000th dialysis machine comes off the production line.

Fresenius Medical Care common stock is admitted to the DAX, Germany’s blue-chip share index.


Photo: 2001

Fresenius acquires Wittgensteiner Kliniken AG, one of the major nationwide operators of private hospitals in Germany.

Fresenius, a health care group with worldwide operations and over 60,000 employees, achieves sales of around 7.3 billion euros.


Photo: 2003

With an output of more than 50 million dialyzers per year, Fresenius Medical Care sets a new record.


Photo: HELIOS Klinikum Berlin-Buch 2005

Fresenius acquires HELIOS, one of the top three private hospital operators in Germany.


Photo: 2006

Fresenius Medical Care takes over U.S. dialysis care provider Renal Care Group. Through its network of approximately 2,000 dialysis clinics in North America, Europe, Latin America, Asia-Pacific and Africa, Fresenius Medical Care provides dialysis treatment to approximately 157,000 patients around the globe.


Photo: 2007

Fresenius becomes a European Company (SE).


Photo: Image History 2008

Fresenius Kabi strengthens its business with intravenously administered generic drugs (I.V. generics) and expands into oncology drugs with the acquisition of the Indian company Dabur Pharma.

Fresenius Kabi enters into the North American pharmaceuticals market and becomes a globally leading company in the field of I.V. generics via the acquisition of the U.S. based APP Pharmaceuticals.

 


Photo: 2009

Fresenius SE’s preferred shares are admitted to the DAX index.


Photo: 2011

Conversion of all preference shares into ordinary shares in combination with a change of the company’s legal form into a partnership limited by shares – Kommanditgesellschaft auf Aktien (KGaA). Fresenius SE becomes Fresenius SE & Co. KGaA.


Photo: F100 Logo 2012

As Fresenius turns 100, the company is active in some 100 countries and has more than 160,000 employees.

 

Fresenius Medical Care produces the 500,000th dialysis machine.